本页面由Tiger Trade Technology Pte. Ltd.提供服务

Janux Therapeutics, Inc.

18.15
-0.2400-1.31%
盘前:18.680.5312+2.93%04:22 EDT
成交量:80.30万
成交额:1,459.59万
市值:11.10亿
市盈率:-11.05
高:18.61
开:18.29
低:17.96
收:18.39
52周最高:35.34
52周最低:12.12
股本:6,113.68万
流通股本:4,252.58万
量比:0.77
换手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):-1.6429
每股收益(LYR):-1.8336
净资产收益率:-10.70%
总资产收益率:-8.80%
市净率:1.20
市盈率(LYR):-9.90

数据加载中...

2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/22

重要事件披露

Form 8-K - Current report
2024/06/28

重要事件披露

Form 8-K - Current report
2024/06/05

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/03/08

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/08

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]